BIES: Robert Plenge, Bristol Myers Squibb

Tue May 28 2024 at 04:30 pm to 06:00 pm

Online | Online

Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics
Publisher/HostHarvard Office of Technology Development and the HMS Dept. of Biomedical Informatics
BIES: Robert Plenge, Bristol Myers Squibb
Advertisement
A monthly conversation about medicine, biology, computers, and entrepreneurship.
About this Event

Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics.

Open to all, in person at Harvard Medical School, Gordon Hall Room 106, The Waterhouse Room or online via Zoom.

In-person networking with food and drink from 4:30-5:00pm, followed by presentation by speaker at 5:00pm, broadcasted online via Zoom.



Featured Speaker:

Robert Plenge, MD, PhD, Executive Vice President, Chief Research Officer and Head of Research at Bristol Myers Squibb

This Entrepreneurs Salon will be hosted by Isaac Kohane, Chair, Department of Biomedical Informatics, Harvard Medical School.



Location:

We are pleased to return for another hybrid Salon event. All are welcome to join us at Gordon Hall, Room 106, The Waterhouse Room, at Harvard Medical School in Boston. For those unable to attend in person, we welcome you to join us on Zoom (access the Zoom registration link via Eventbrite's "Online Event Page" after registering with Eventbrite). However you plan to join us, please register here with Eventbrite.

This Entrepreneurs Salon will be hosted by Isaac Kohane, Chair, Department of Biomedical Informatics, Harvard Medical School.


Event Photos

Robert Plenge, MD, PhD, is executive vice president, chief research officer and head of Research at Bristol Myers Squibb. He leads scientific activities across eleven research sites around the world all focused on transforming patients’ lives through science.

Prior to his current role, Robert served as head of Discovery & Translational Sciences at Bristol Myers Squibb, which spanned all therapeutic areas at the company. Robert joined BMS as part of the acquisition of Celgene in November 2019. At Celgene, he served as vice president, Immunology & Inflammation portfolio, Research & Early Development. Prior to joining Celgene, Robert was vice president and Head of Translational Medicine at Merck.

Robert received his MD and PhD from Case Western Reserve University and holds a BS from the University of California, San Diego. He completed his internal medicine residency as a molecular medicine fellow at the University of California, San Francisco. He served as rheumatology fellow at Brigham & Women’s Hospital and postdoctoral research fellow at the Broad Institute of MIT and Harvard. He was an assistant professor of medicine at Harvard Medical School and an associate member of the Broad Institute while practicing clinical rheumatology and running a research laboratory at Brigham & Women’s Hospital.

Robert is an author of more than 125 manuscripts published in peer-reviewed journals, and frequently posts updates to his personal blog, Plenge Gen, commenting on critical discovery moments with a focus on the resulting patient impact. He is a recipient of several academic and corporate awards and currently serves on the Board of Directors for the PhRMA Foundation.


FUTURE COMMUNICATIONS:

Please note: By registering, you agree to receive emails about this event and future communications from Harvard OTD.

Advertisement

Event Venue

Online

Tickets

USD 0.00

Sharing is Caring: